I L Dodge1, G Demirci, T B Strom, X C Li. 1. Department of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA.
Abstract
BACKGROUND: Under certain conditions rapamycin and transforming growth factor- (TGF) beta have similar immunoregulatory effects, suggesting a potential functional link between rapamycin and TGF-beta. METHODS: Splenic leukocytes were stimulated in vitro with anti-CD3 or with allogeneic cells in vivo in the presence or absence of rapamycin. TGF-beta production by activated lymphocytes was quantitated using ELISA. RESULTS: Splenic leukocytes from BALB/c mice that were primed with allogeneic cells and conditioned with rapamycin in vivo as well as splenic leukocytes that were treated with rapamycin in vitro produced significantly higher levels of TGF-beta upon anti-CD3 stimulation as compared with untreated controls. CONCLUSION: Our data suggest that rapamycin can program activated lymphocytes to produce TGF-beta. Thus, the immunosuppressive effects of rapamycin may be partially mediated by TGF-beta.
BACKGROUND: Under certain conditions rapamycin and transforming growth factor- (TGF) beta have similar immunoregulatory effects, suggesting a potential functional link between rapamycin and TGF-beta. METHODS: Splenic leukocytes were stimulated in vitro with anti-CD3 or with allogeneic cells in vivo in the presence or absence of rapamycin. TGF-beta production by activated lymphocytes was quantitated using ELISA. RESULTS: Splenic leukocytes from BALB/c mice that were primed with allogeneic cells and conditioned with rapamycin in vivo as well as splenic leukocytes that were treated with rapamycin in vitro produced significantly higher levels of TGF-beta upon anti-CD3 stimulation as compared with untreated controls. CONCLUSION: Our data suggest that rapamycin can program activated lymphocytes to produce TGF-beta. Thus, the immunosuppressive effects of rapamycin may be partially mediated by TGF-beta.
Authors: Moanaro Biswas; Debalina Sarkar; Sandeep R P Kumar; Sushrusha Nayak; Geoffrey L Rogers; David M Markusic; Gongxian Liao; Cox Terhorst; Roland W Herzog Journal: Blood Date: 2015-04-01 Impact factor: 22.113
Authors: Josh Levitsky; Lorenzo Gallon; Joshua Miller; Anat R Tambur; Joseph Leventhal; Catherine Flaa; Xuemei Huang; Bara Sarraj; Edward Wang; James M Mathew Journal: Transplantation Date: 2011-01-27 Impact factor: 4.939
Authors: James I Kim; Matthew R O'connor; Patrick E Duff; Gaoping Zhao; Kang Mi Lee; Philip Eliades; Shaoping Deng; Heidi Yeh; Andrew J Caton; James F Markmann Journal: Transplantation Date: 2011-04-15 Impact factor: 4.939
Authors: Michael Schäffer; Robert Schier; Markus Napirei; Stefan Michalski; Thilo Traska; Richard Viebahn Journal: Langenbecks Arch Surg Date: 2007-03-24 Impact factor: 2.895